ErbB2 overexpression has been described in several types of neoplastic processes, including breast and gastric cancer amongst others [8], and is associated with increased aggressiveness, significantly shortened disease-free and overall survival [9,10]. The gene discussed is ERBB2; the disease is gastric cancer.